Researchers from the University of Maryland investigated factors influencing Black individuals with cancer when deciding whether to enroll in clinical trials. Their findings were presented at the 2024 American Society for Radiation Oncology Annual Meeting. The team collected questionnaires from 97 patients undergoing definitive radiation treatment for gastrointestinal, thoracic, gynecological, and head and neck cancers. Thirty percent of participants were Black (n=42). Black participants were predominantly female and were less likely to be married, had lower median income, and had more comorbidities ...
Advertisement
Up to one-third of patients who reported food, housing, or utility insecurity also had private insurance.
Puerto Ricans with breast cancer patients suffer noble health disparities compared to non-Hispanic Whites and Hispanics.
A study looked at cytomolecular risk profiles in Black and Hispanic patients according to clinical trial enrollment.
transgender status was not a predictor of prostate cancer-related death.
These findings highlight the importance of racial diversity in genomic profiling and clinical trials.
Moderate or severe and penetrating traumatic brain injuries may be potentially novel risk factors for brain cancer in vets.
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
Urban Health Weekly
Dr. Daniel Von Hoff on the $150M Stephenson Prize to Advance Pancreatic Cancer Research
Dr. Sherri Onyiego Discusses Value-Based Care for improved healthcare access.
Angela Talton on City of Hope's recent partnership with Charles R. Drew University of Medicine & Science for diversity.
Dr. Chris Reddick discusses Takéda’s expanded partnership with Partners In Health (PIH) for better healthcare access.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.